1. 食品类（Food Products）a. 食品设施注册（Food Facility Registration）所有出口到美国的食品，或在...
Food and Drug Administration has issued warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act. Topics include the letters address the illegal marketing of unapproved CBD products claiming to treat medical conditions...
Here's a breakdown in the differences between CBD and THC, the main chemical compounds in marijuana plants. The Food and Drug Administration said Thursday there are too many unknowns about CBD products to regulate them as foods or supplements under the agency’s current structure and called ...
"The FDA's existing foods and dietarysupplementauthorities provide only limited tools for managing many of the risks associated with CBD products," Woodcock added. "Given the available evidence, it is not apparent how CBD products could meet safety standards fordietary supplementsor food additives."...
The US Food and Drug Administration (FDA) has sent a warning letter to Curaleaf Inc of Wakefield, Massachusetts, for illegally selling unapproved products containingcannabidiol(CBD) online with unsubstantiated claims that the products treat cancer,Alzheimer's disease, opioid withdrawal, pain, and other...
THE DETAILSThe agency said that it needed to monitor products containing CBD more closely due to the safety risks involved, particularly to pregnant women and children. THE WHY?FDA Principal Deputy Commissioner, Janet Woodcock told The Wall Street Journal, “Given the available evidence, it is not...
no CBD-containing drug has met applicable FDA requirements to be legally marketed for nonprescription use. As explained below, nonprescription drug products that include CBD as an active ingredient are not generally recognized as safe and effective (GRASE) ...
CBD Product Testing Pharmaceutical Water Testing Method Development & Validation Expertise Low Level Detection and Claims 1,4-Dioxane Regulatory Change Preservatives, Antiseptic Products Testing Systems Validation Programs Drug Batch Release USP Container Testing ...
“Today’s FDA announcement underscores the urgent need for Congress and the government to take swift action to modernize federal cannabis policy and regulate CBD and other products appropriately and in harmony with the vast majority of states that have already legalized cannabis in some form,...
“today’s announcement by the fda underscores the urgent need for congress and the administration to take swift action to modernize federal cannabis policy and regulate cbd and other products appropriately and in harmony with the vast majority of states that have already legalized cannabis in some...